US Stock MarketDetailed Quotes

PTC Therapeutics (PTCT)

Watchlist
  • 71.470
  • -1.250-1.72%
Close May 15 16:00 ET
  • 71.470
  • 0.0000.00%
Post 20:01 ET
5.93BMarket Cap-31.21P/E (TTM)

PTC Therapeutics (PTCT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-106.79%-59.04M
760.42%711.2M
-14.23%-34.27M
13.89%-66.3M
18.36%-58.33M
1,129.64%870.1M
32.02%-107.69M
70.08%-30M
-430.28%-76.99M
-406.04%-71.45M
Net income from continuing operations
-100.32%-2.81M
287.90%682.64M
-104.85%-134.97M
114.90%15.9M
34.61%-64.85M
1,046.28%866.56M
42.02%-363.3M
57.71%-65.89M
19.79%-106.65M
50.13%-99.18M
Operating gains losses
-98.28%40K
287.65%10.75M
157.17%5.69M
-93.11%45K
-2.64%2.69M
186.35%2.33M
-114.80%-5.73M
-128.94%-9.96M
-96.10%653K
216.99%2.76M
Depreciation and amortization
113.45%15.41M
-48.70%38.82M
90.75%12.9M
71.28%11.11M
8.05%7.58M
-86.96%7.22M
-68.02%75.66M
-91.62%6.76M
-89.55%6.49M
-86.24%7.02M
Deferred tax
-600.00%-10K
99.99%-3K
100.00%1K
-33.33%-4K
-200.00%-2K
300.00%2K
-19.14%-55.91M
-1,505.13%-55.91M
-50.00%-3K
100.00%2K
Other non cash items
57.46%20.93M
73.43%-20.98M
80.54%-22.19M
-544.01%-11.78M
-103.09%-311K
-50.45%13.29M
24.54%-78.98M
-2,306.40%-114.03M
-241.45%-1.83M
108.20%10.05M
Change In working capital
-196.01%-110.7M
-146.69%-47.88M
149.09%91.11M
-829.68%-84.88M
-49.58%-16.72M
-157.09%-37.4M
2,661.65%102.54M
144.28%36.58M
54.97%11.63M
-134.51%-11.18M
-Change in receivables
15.49%-40.39M
-686.09%-10.15M
-45.50%22.21M
16.13%-6.47M
167.41%21.9M
-20.99%-47.79M
212.54%1.73M
388.27%40.76M
-194.89%-7.72M
-67.76%8.19M
-Change in inventory
20.63%2.64M
-974.37%-53.9M
-341.56%-26.78M
-496.46%-18.53M
-456.92%-10.78M
1,725.83%2.19M
175.33%6.16M
86.70%11.09M
28.20%-3.11M
62.65%-1.94M
-Change in prepaid assets
97.61%-408K
-130.73%-34.18M
-369.53%-21.81M
-89.21%649K
-15.58%4.02M
-116.21%-17.04M
379.66%111.22M
95.53%-4.64M
188.13%6.01M
-62.04%4.76M
-Change in payables and accrued expense
-471.38%-68.71M
315.30%71.74M
428.47%108.08M
-336.29%-43.21M
12.58%-11.64M
443.33%18.5M
-168.92%-33.32M
-515.89%-32.91M
128.65%18.29M
-1,124.75%-13.31M
-Change in other current liabilities
-404.15%-2.31M
-247.05%-17.4M
-45.05%9.1M
-398.48%-9.18M
-89.97%-16.86M
-107.65%-458K
612.79%11.83M
3,105.99%16.56M
-241.72%-1.84M
-1,051.34%-8.88M
-Change in other working capital
-121.14%-1.52M
-181.31%-4M
-94.75%300K
---8.14M
---3.36M
998.88%7.2M
994.00%4.92M
1,451.77%5.72M
--0
--0
Cash from discontinued investing activities
Operating cash flow
-106.79%-59.04M
760.42%711.2M
-14.23%-34.27M
13.89%-66.3M
18.36%-58.33M
1,129.64%870.1M
32.02%-107.69M
70.08%-30M
-430.28%-76.99M
-406.04%-71.45M
Investing cash flow
Cash flow from continuing investing activities
49.16%-93.74M
-2,050.98%-861.98M
-87.30%34.01M
-578.67%-289.62M
-540.15%-422.01M
-60.41%-184.36M
125.00%44.18M
383.54%267.71M
-44.19%-42.68M
-177.55%-65.92M
Net PPE purchase and sale
27.63%-1.2M
-140.78%-8.79M
36.98%-2.37M
-583.53%-3.45M
-103.72%-1.32M
82.75%-1.65M
175.79%21.55M
32.32%-3.77M
92.07%-504K
667.06%35.41M
Net intangibles purchase and sale
80.69%-156K
-329.76%-291.15M
-1,179.01%-34.92M
-2,364.89%-252.75M
---2.68M
98.52%-808K
26.51%-67.75M
88.08%-2.73M
55.12%-10.25M
--0
Net investment purchase and sale
49.21%-92.38M
-842.63%-562.04M
-42.60%71.3M
-4.73%-33.43M
-312.50%-418.02M
-259.62%-181.9M
-6.25%-59.63M
288.32%124.21M
-8,083.85%-31.92M
-2,168.04%-101.34M
Net other investing changes
----
----
----
----
----
----
--150M
----
----
----
Cash from discontinued investing activities
Investing cash flow
49.16%-93.74M
-2,050.98%-861.98M
-87.30%34.01M
-578.67%-289.62M
-540.15%-422.01M
-60.41%-184.36M
125.00%44.18M
383.54%267.71M
-44.19%-42.68M
-177.55%-65.92M
Financing cash flow
Cash flow from continuing financing activities
-31.96%6.4M
29.40%331.09M
1,042.78%302.5M
186.34%15.22M
-98.39%3.96M
1,642.59%9.41M
-60.42%255.87M
-95.73%26.47M
-624.46%-17.63M
1,235.22%246.48M
Net issuance payments of debt
----
-8.12%-1.61M
--0
---1.61M
--0
--0
99.51%-1.49M
--0
--0
--0
Net common stock issuance
----
----
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
-59.35%6.4M
193.35%99.05M
136.12%62.5M
2,837.17%16.83M
-15.54%3.96M
675.91%15.75M
12.57%33.76M
994.75%26.47M
-83.37%573K
-74.61%4.69M
Net other financing activities
----
4.50%233.66M
--240M
--0
--0
---6.34M
-75.64%223.59M
--0
-21,311.76%-18.2M
----
Cash from discontinued financing activities
Financing cash flow
-31.96%6.4M
29.40%331.09M
1,042.78%302.5M
186.34%15.22M
-98.39%3.96M
1,642.59%9.41M
-60.42%255.87M
-95.73%26.47M
-624.46%-17.63M
1,235.22%246.48M
Net cash flow
Beginning cash position
25.53%998.33M
30.32%795.32M
27.14%686.3M
54.53%1.03B
164.93%1.5B
30.32%795.32M
106.23%610.28M
197.55%539.79M
197.80%668.54M
141.71%564.62M
Current changes in cash
-121.06%-146.38M
-6.27%180.31M
14.41%302.24M
-148.16%-340.71M
-536.62%-476.38M
1,693.25%695.15M
-38.20%192.36M
-37.95%264.18M
-236.88%-137.29M
662.05%109.11M
Effect of exchange rate changes
-128.26%-1.52M
409.93%22.71M
213.20%9.8M
-170.99%-6.06M
361.96%13.59M
365.67%5.39M
-335.32%-7.33M
-379.58%-8.65M
466.30%8.54M
-150.29%-5.19M
End cash Position
-43.15%850.44M
25.53%998.33M
25.53%998.33M
27.14%686.3M
54.53%1.03B
164.93%1.5B
30.32%795.32M
30.32%795.32M
197.55%539.79M
197.80%668.54M
Free cash flow
-106.96%-60.4M
326.00%411.18M
-96.06%-71.56M
-267.44%-322.5M
2.73%-62.33M
13,434.65%867.57M
34.80%-181.94M
71.65%-36.5M
-100.73%-87.77M
-91.83%-64.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -106.79%-59.04M760.42%711.2M-14.23%-34.27M13.89%-66.3M18.36%-58.33M1,129.64%870.1M32.02%-107.69M70.08%-30M-430.28%-76.99M-406.04%-71.45M
Net income from continuing operations -100.32%-2.81M287.90%682.64M-104.85%-134.97M114.90%15.9M34.61%-64.85M1,046.28%866.56M42.02%-363.3M57.71%-65.89M19.79%-106.65M50.13%-99.18M
Operating gains losses -98.28%40K287.65%10.75M157.17%5.69M-93.11%45K-2.64%2.69M186.35%2.33M-114.80%-5.73M-128.94%-9.96M-96.10%653K216.99%2.76M
Depreciation and amortization 113.45%15.41M-48.70%38.82M90.75%12.9M71.28%11.11M8.05%7.58M-86.96%7.22M-68.02%75.66M-91.62%6.76M-89.55%6.49M-86.24%7.02M
Deferred tax -600.00%-10K99.99%-3K100.00%1K-33.33%-4K-200.00%-2K300.00%2K-19.14%-55.91M-1,505.13%-55.91M-50.00%-3K100.00%2K
Other non cash items 57.46%20.93M73.43%-20.98M80.54%-22.19M-544.01%-11.78M-103.09%-311K-50.45%13.29M24.54%-78.98M-2,306.40%-114.03M-241.45%-1.83M108.20%10.05M
Change In working capital -196.01%-110.7M-146.69%-47.88M149.09%91.11M-829.68%-84.88M-49.58%-16.72M-157.09%-37.4M2,661.65%102.54M144.28%36.58M54.97%11.63M-134.51%-11.18M
-Change in receivables 15.49%-40.39M-686.09%-10.15M-45.50%22.21M16.13%-6.47M167.41%21.9M-20.99%-47.79M212.54%1.73M388.27%40.76M-194.89%-7.72M-67.76%8.19M
-Change in inventory 20.63%2.64M-974.37%-53.9M-341.56%-26.78M-496.46%-18.53M-456.92%-10.78M1,725.83%2.19M175.33%6.16M86.70%11.09M28.20%-3.11M62.65%-1.94M
-Change in prepaid assets 97.61%-408K-130.73%-34.18M-369.53%-21.81M-89.21%649K-15.58%4.02M-116.21%-17.04M379.66%111.22M95.53%-4.64M188.13%6.01M-62.04%4.76M
-Change in payables and accrued expense -471.38%-68.71M315.30%71.74M428.47%108.08M-336.29%-43.21M12.58%-11.64M443.33%18.5M-168.92%-33.32M-515.89%-32.91M128.65%18.29M-1,124.75%-13.31M
-Change in other current liabilities -404.15%-2.31M-247.05%-17.4M-45.05%9.1M-398.48%-9.18M-89.97%-16.86M-107.65%-458K612.79%11.83M3,105.99%16.56M-241.72%-1.84M-1,051.34%-8.88M
-Change in other working capital -121.14%-1.52M-181.31%-4M-94.75%300K---8.14M---3.36M998.88%7.2M994.00%4.92M1,451.77%5.72M--0--0
Cash from discontinued investing activities
Operating cash flow -106.79%-59.04M760.42%711.2M-14.23%-34.27M13.89%-66.3M18.36%-58.33M1,129.64%870.1M32.02%-107.69M70.08%-30M-430.28%-76.99M-406.04%-71.45M
Investing cash flow
Cash flow from continuing investing activities 49.16%-93.74M-2,050.98%-861.98M-87.30%34.01M-578.67%-289.62M-540.15%-422.01M-60.41%-184.36M125.00%44.18M383.54%267.71M-44.19%-42.68M-177.55%-65.92M
Net PPE purchase and sale 27.63%-1.2M-140.78%-8.79M36.98%-2.37M-583.53%-3.45M-103.72%-1.32M82.75%-1.65M175.79%21.55M32.32%-3.77M92.07%-504K667.06%35.41M
Net intangibles purchase and sale 80.69%-156K-329.76%-291.15M-1,179.01%-34.92M-2,364.89%-252.75M---2.68M98.52%-808K26.51%-67.75M88.08%-2.73M55.12%-10.25M--0
Net investment purchase and sale 49.21%-92.38M-842.63%-562.04M-42.60%71.3M-4.73%-33.43M-312.50%-418.02M-259.62%-181.9M-6.25%-59.63M288.32%124.21M-8,083.85%-31.92M-2,168.04%-101.34M
Net other investing changes --------------------------150M------------
Cash from discontinued investing activities
Investing cash flow 49.16%-93.74M-2,050.98%-861.98M-87.30%34.01M-578.67%-289.62M-540.15%-422.01M-60.41%-184.36M125.00%44.18M383.54%267.71M-44.19%-42.68M-177.55%-65.92M
Financing cash flow
Cash flow from continuing financing activities -31.96%6.4M29.40%331.09M1,042.78%302.5M186.34%15.22M-98.39%3.96M1,642.59%9.41M-60.42%255.87M-95.73%26.47M-624.46%-17.63M1,235.22%246.48M
Net issuance payments of debt -----8.12%-1.61M--0---1.61M--0--099.51%-1.49M--0--0--0
Net common stock issuance --------------------------0------------
Proceeds from stock option exercised by employees -59.35%6.4M193.35%99.05M136.12%62.5M2,837.17%16.83M-15.54%3.96M675.91%15.75M12.57%33.76M994.75%26.47M-83.37%573K-74.61%4.69M
Net other financing activities ----4.50%233.66M--240M--0--0---6.34M-75.64%223.59M--0-21,311.76%-18.2M----
Cash from discontinued financing activities
Financing cash flow -31.96%6.4M29.40%331.09M1,042.78%302.5M186.34%15.22M-98.39%3.96M1,642.59%9.41M-60.42%255.87M-95.73%26.47M-624.46%-17.63M1,235.22%246.48M
Net cash flow
Beginning cash position 25.53%998.33M30.32%795.32M27.14%686.3M54.53%1.03B164.93%1.5B30.32%795.32M106.23%610.28M197.55%539.79M197.80%668.54M141.71%564.62M
Current changes in cash -121.06%-146.38M-6.27%180.31M14.41%302.24M-148.16%-340.71M-536.62%-476.38M1,693.25%695.15M-38.20%192.36M-37.95%264.18M-236.88%-137.29M662.05%109.11M
Effect of exchange rate changes -128.26%-1.52M409.93%22.71M213.20%9.8M-170.99%-6.06M361.96%13.59M365.67%5.39M-335.32%-7.33M-379.58%-8.65M466.30%8.54M-150.29%-5.19M
End cash Position -43.15%850.44M25.53%998.33M25.53%998.33M27.14%686.3M54.53%1.03B164.93%1.5B30.32%795.32M30.32%795.32M197.55%539.79M197.80%668.54M
Free cash flow -106.96%-60.4M326.00%411.18M-96.06%-71.56M-267.44%-322.5M2.73%-62.33M13,434.65%867.57M34.80%-181.94M71.65%-36.5M-100.73%-87.77M-91.83%-64.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More